Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nextsense Brain-sensing Buds Study

NCT06602960 is registered in ClinicalTrials.gov with NextSense, Inc. as lead sponsor.

NCT NCT06602960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06602960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nextsense Brain-sensing Buds Study
Lead sponsor
NextSense, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
October 7, 2024
Completion date
April 15, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep, sleep quality, sleepiness, daytime, technology